GLI1 and esophageal cancer: Studies have indicated that GLI1 abnormally expresses in breast cancer [33], colorectal cancer [1], esophageal cancer [40] and other malignant tumors, and can also regulate the activity of other transcription factors to stimulate the proliferation, differentiation, and transformation of tumor cell.